Malaysia has granted a conditional registration for an affordable hepatitis C treatment developed through public-private partnerships with organizations in Egypt and Thailand.
Singapore's Health Sciences Authority has granted conditional approval of remdesivir as a treatment for patients with severe COVID-19.
Tagrisso, a small molecule inhibitor drug, has been approved in China as a first-line treatment for patients with non-small cell lung tumors bearing specific mutations.
A procedure that cuts off blood supply to tumors, combined with a small molecule inhibitor drug sorafenib, improves the survival of advanced-stage liver cancer patients.
Innovent Biologics' CT103A, a promising therapy for tough-to-treat blood cancer, has shown positive results in clinical trials.
Two studies on the financial and pharmaceutical industries highlight the protective role of regulations and the human cost when companies place self-interest over compliance.